Annual Revenue
$60.00 M
+$33.42 M+125.73%
31 December 2023
Summary:
Protagonist Therapeutics annual revenue is currently $60.00 million, with the most recent change of +$33.42 million (+125.73%) on 31 December 2023. During the last 3 years, it has risen by +$32.64 million (+119.32%). PTGX annual revenue is now at all-time high.PTGX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$4.67 M
+$508.00 K+12.19%
30 September 2024
Summary:
Protagonist Therapeutics quarterly revenue is currently $4.67 million, with the most recent change of +$508.00 thousand (+12.19%) on 30 September 2024. Over the past year, it has dropped by -$55.33 million (-92.21%). PTGX quarterly revenue is now -98.17% below its all-time high of $254.95 million, reached on 31 March 2024.PTGX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$323.80 M
+$4.67 M+1.46%
30 September 2024
Summary:
Protagonist Therapeutics TTM revenue is currently $323.80 million, with the most recent change of +$4.67 million (+1.46%) on 30 September 2024. Over the past year, it has increased by +$263.80 million (+439.66%). PTGX TTM revenue is now at all-time high.PTGX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTGX Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -92.2% | +439.7% |
| 3 y3 years | +119.3% | -45.8% | +1083.6% |
| 5 y5 years | +10000.0% | +71.9% | +10000.0% |
PTGX Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +125.7% | -98.2% | +444.2% | at high | +1083.6% |
| 5 y | 5 years | at high | >+9999.0% | -98.2% | +444.2% | at high | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -98.2% | +157.1% | at high | >+9999.0% |
Protagonist Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $4.67 M(+12.2%) | $323.80 M(+1.5%) |
| June 2024 | - | $4.17 M(-98.4%) | $319.12 M(+1.3%) |
| Mar 2024 | - | $254.95 M(+324.9%) | $314.95 M(+424.9%) |
| Dec 2023 | $60.00 M(+125.7%) | $60.00 M(+6884.9%) | $60.00 M(+31.9%) |
| Dec 2022 | $26.58 M(-2.8%) | - | - |
| June 2022 | - | $859.00 K(-96.7%) | $45.48 M(-3.0%) |
| Mar 2022 | - | $25.72 M(+198.5%) | $46.89 M(+71.4%) |
| Dec 2021 | $27.36 M(-4.4%) | $8.62 M(-16.2%) | $27.36 M(+12.2%) |
| Sept 2021 | - | $10.29 M(+354.1%) | $24.39 M(-10.4%) |
| June 2021 | - | $2.27 M(-63.4%) | $27.22 M(-12.7%) |
| Mar 2021 | - | $6.19 M(+9.5%) | $31.17 M(+8.9%) |
| Dec 2020 | $28.63 M | $5.65 M(-56.9%) | $28.63 M(+11.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | $13.11 M(+110.9%) | $25.70 M(+53.7%) |
| June 2020 | - | $6.22 M(+70.5%) | $16.72 M(+621.5%) |
| Mar 2020 | - | $3.65 M(+34.1%) | $2.32 M(+903.5%) |
| Dec 2019 | $231.00 K(-99.3%) | $2.72 M(-34.3%) | $231.00 K(-271.1%) |
| Sept 2019 | - | $4.14 M(-150.6%) | -$135.00 K(-107.3%) |
| June 2019 | - | -$8.19 M(-624.9%) | $1.84 M(-91.5%) |
| Mar 2019 | - | $1.56 M(-33.7%) | $21.70 M(-29.8%) |
| Dec 2018 | $30.93 M(+54.1%) | $2.35 M(-61.5%) | $30.93 M(-22.4%) |
| Sept 2018 | - | $6.12 M(-47.6%) | $39.85 M(-6.3%) |
| June 2018 | - | $11.67 M(+8.3%) | $42.52 M(+37.8%) |
| Mar 2018 | - | $10.78 M(-4.4%) | $30.84 M(+53.7%) |
| Dec 2017 | $20.06 M | $11.28 M(+28.5%) | $20.06 M(+128.5%) |
| Sept 2017 | - | $8.78 M | $8.78 M |
FAQ
- What is Protagonist Therapeutics annual revenue?
- What is the all time high annual revenue for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly revenue year-on-year change?
- What is Protagonist Therapeutics TTM revenue?
- What is the all time high TTM revenue for Protagonist Therapeutics?
- What is Protagonist Therapeutics TTM revenue year-on-year change?
What is Protagonist Therapeutics annual revenue?
The current annual revenue of PTGX is $60.00 M
What is the all time high annual revenue for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual revenue is $60.00 M
What is Protagonist Therapeutics quarterly revenue?
The current quarterly revenue of PTGX is $4.67 M
What is the all time high quarterly revenue for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly revenue is $254.95 M
What is Protagonist Therapeutics quarterly revenue year-on-year change?
Over the past year, PTGX quarterly revenue has changed by -$55.33 M (-92.21%)
What is Protagonist Therapeutics TTM revenue?
The current TTM revenue of PTGX is $323.80 M
What is the all time high TTM revenue for Protagonist Therapeutics?
Protagonist Therapeutics all-time high TTM revenue is $323.80 M
What is Protagonist Therapeutics TTM revenue year-on-year change?
Over the past year, PTGX TTM revenue has changed by +$263.80 M (+439.66%)